MEDVi starts at $179/mo (all-in, includes medication); Sprout at $149/mo (all-in, includes medication). Both prescribe GLP-1 medication — MEDVi offers compounded semaglutide & tirzepatide, Sprout compounded semaglutide & tirzepatide. Here's how they compare on price, medications, support and transparency.
Bottom line: MEDVi wins
MEDVi wins on our rubric, 8.2/10 to 7.7/10. It leads most on transparency. Choose Sprout instead if you want the lower entry price — $149/mo vs $179/mo.
Round by round
We scored both programs on the four factors in our methodology — value, support, medications and transparency. MEDVi takes 2, Sprout takes 0, with 2 even. Here's how each shook out.
Value
What you get for the price — not just the lowest sticker. A premium program that includes FDA-approved medication, insurance help and real support can be good value. Evenly matched at about 7.8.
Support
Real clinician access, coaching and follow-up — video visits and a care team score higher than async-only. MEDVi scores 8.0 to 7.4 — ahead.
Medications
Medication options and legitimacy — FDA-approved branded (Wegovy, Zepbound) rates above compounded-only, and breadth and flexibility add points. Evenly matched at about 8.4.
Transparency
How clearly and publicly pricing, terms and availability are stated — plus track record and any regulatory red flags. MEDVi scores 8.4 to 7.4 — clearly ahead.
Where they differ most
The clearest daylight is in transparency, where MEDVi leads 8.4 to 7.4 and support, where MEDVi leads 8.0 to 7.4. On price, Sprout starts lower ($149 vs $179 per month).
Pricing: MEDVi vs Sprout
Sprout has the lower advertised starting price — $149/mo vs $179/mo for MEDVi. But read the fine print: MEDVi is all-in, includes medication and Sprout is all-in, includes medication, and the cheapest rates often need a prepaid multi-month plan — so compare the real all-in cost at your maintenance dose, not the headline. We unpack how these plans are structured in how much compounded semaglutide costs.
MEDVi: On 12-month prepay; month-to-month is $299/mo; tirzepatide higher (as of 2026, health.usnews.com). Sprout: Intro starting rate; ongoing ~$249/mo (semaglutide) / ~$299/mo (tirzepatide) (as of Sep 2026, health.usnews.com).
The specs, side by side
| MEDVi | Sprout | |
|---|---|---|
| Editor rating | 8.2/10 · Very good | 7.7/10 · Good |
| Starting price | $179/mo | $149/mo |
| Pricing | All-in, includes medication | All-in, includes medication |
| Medications | Compounded semaglutide & tirzepatide | Compounded semaglutide & tirzepatide |
| Medication form | Weekly injection | Weekly injection |
| Visit type | Async, ~24h provider review | Async questionnaire + monthly check-ins |
| Insurance | Cash-pay (HSA/FSA) | Cash-pay |
| Availability | All 50 states | Nationwide (excl. AL, AR, CA, LA, MS, ND) |
Which should you pick?
Choose MEDVi if…
You want stronger clinical support — more clinician time, coaching and follow-up.
View MEDVi plans →Common questions
Is MEDVi better than Sprout?
In our scoring MEDVi comes out ahead — 8.2/10 to 7.7/10, leading on transparency. It's our pick for most people; Sprout is the better choice if you want the lower entry price — $149/mo vs $179/mo.
Which is cheaper, MEDVi or Sprout?
Sprout has the lower advertised starting price — $149/mo vs $179/mo for MEDVi. But read the fine print: MEDVi is all-in, includes medication and Sprout is all-in, includes medication, and the cheapest rates often need a prepaid multi-month plan — so compare the real all-in cost at your maintenance dose, not the headline.
Do MEDVi and Sprout prescribe the same medications?
MEDVi offers compounded semaglutide & tirzepatide (weekly injection); Sprout offers compounded semaglutide & tirzepatide (weekly injection). On breadth of options, MEDVi scores higher. Compounded GLP-1s aren't FDA-approved finished products, and availability shifts — confirm current options with each provider.
Which gives you more support, MEDVi or Sprout?
MEDVi scores higher on support — real clinician access, coaching and follow-up. For visits, MEDVi is async, ~24h provider review and Sprout is async questionnaire + monthly check-ins.
Are MEDVi and Sprout legit?
Both require a licensed clinician to review your intake before prescribing. Confirm each provider's credentials, state availability (MEDVi: all 50 states; Sprout: nationwide (excl. al, ar, ca, la, ms, nd)) and current pricing before you sign up — and note that compounded medications aren't FDA-approved.
Can I switch between MEDVi and Sprout?
Generally yes — neither locks you into a long contract, though the lowest prices often require a prepaid plan. Never stop or change a GLP-1 medication without talking to your clinician first.
Both programs are scored with the same independent methodology. We may earn a commission from either provider — it changes nothing about the scores or the verdict. Prices are advertised starting rates as of October 2026; confirm current pricing with each provider. Nothing here is medical advice.